Ecophysiological traits associated with the competitive ability of invasive Australian acacias

Aim We explored morphological and ecophysiological traits that enable invasive Australian acacias to compete with native species for resources (light, water and nutrients) necessary to support the substantial growth associated with successful invasions. Location Global. Results Invasive Australian acacias grow large and seed prolifically in invaded regions. The greater capacity for vegetative growth is underpinned by their ability to acquire and efficiently use resources in non-native habitats. Key biological traits that enhance acquisition include (1) rapid and substantial allocation to root mass (up to 6-fold more than co-occurring native species) directed towards deep roots (at least 50% longer than those of natives) and to extensive shallow root networks; (2) heteroblasty, in most species, conferring high relative growth rates as bipinnate seedlings but long-lived, nutrient- onserving phyllodes as adults and (3) strong N2-fixation abilities. Main conclusions The ecophysiological traits that govern the competitive interaction of invasive Australian acacias with native species are an important component of the recognized suite of factors including introduction history, human use and enemy release that combine to produce successful invasions. Traits interact to give Australian acacias competitive advantage over many native species. One such interaction is that of N2 fixation, which when coupled with slow decomposition of sclerophyllous phyllodes results in alteration of soil nutrient cycling. The lasting legacy of soil N-enrichment hinders the competitive ability of native species and further enhances invasions. The importance of edaphic factors and competitive interactions in determining invasive success should be considered in predictive modelling of species distributions.Centre of Excellence for Invasion Biolog

Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence

Initial studies of catheter-based renal denervation (RDN) for uncontrolled HTN using radiofrequency ablation in the main renal arteries showed that RDN was effective in lowering office blood pressure (BP). However, the first randomized sham-controlled trial, SYMPLICITY-HTN-3, did not show significantly lower office or 24-h ambulatory systolic BP compared with sham treatment. Subsequent studies in both animals and humans demonstrated the potential importance of more distal and branch renal artery radiofrequency ablation, and a second-generation multielectrode system became available. Two recent randomized sham-controlled trials in patients not taking antihypertensive drugs (SPYRAL HTN-OFF MED) or continuing to take drugs (SPYRAL HTN-ON MED) performed RDN with the second-generation radiofrequency ablation system using an ablation protocol that included treatment of the distal renal artery as well as the branch renal arteries. These studies showed that RDN significantly reduced office and 24-h ambulatory BP compared with sham treatment. Another recent randomized sham-controlled trial in patients not receiving medications showed that RDN with catheter-based ultrasound (RADIANCE-HTN SOLO) applied in just the main renal arteries significantly lowered daytime ambulatory and office BP compared with sham treatment. These trials have renewed clinical and scientific interest in defining the appropriate role of RDN in hypertension treatment. In addition, other important issues will need to be addressed in the future such as the development of tests to determine the extent of RDN at the time of the procedure and the potential of renal nerve fibers to regain their patency at some later stage following the ablation procedure. © 2019 American College of Cardiology Foundatio